Lonza | LONN - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Akzo Nobel EUR 251M 3M 2026-06
Alcon AG USD 44M 253M 2026-06
Almirall EUR 71.55M 41.32M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
BASF EUR 1.43B 31M 2026-06
Bayer EUR 827M 2.7B 2026-06
Beiersdorf EUR 504M 312M 2025-12
Covestro EUR -324M 5.72B 2025-12
Demant DKK 2.12B 35M 2026-06
Fresenius EUR 719M 118M 2026-06
Fresenius Medical Care EUR 537.27M 269.27M 2026-06
Geberit CHF 134.1M 65.8M 2025-12
Genmab DKK 407M 182M 2026-06
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.6B 312M 2026-06
GN Store Nord DKK 58M 126M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Johnson Matthey GBP 198M 56M 2026-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 4.75B 515M 2026-06
Philips EUR 610M 308M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
Sika AG CHF 724.9M 73.2M 2025-12
Smith & Nephew USD 505M 65M 2026-06
Solvay EUR 73M 45M 2026-06
UCB EUR 1.29B 571M 2025-12